Fig 2. Data workflow.

Patients from our prospectively maintained registry were selected based on their imaging and treatment protocols. CT exams were collected. All liver metastases were manually segmented. For each metastasis, 3-D radiomics were extracted and indexed, allowing multiple aggregation strategies. The radiomics signatures were used to stratify the risk of tumor recurrence and patient survival. CT = computed tomography.